An Open-label Prospective Study to Evaluate the Efficacy and Safety of Pegfilgrastim in Triple-Negative Breast Cancer Patients Receiving AC Regimen Following Paclitaxel and Carboplatin as Neoadjuvant Therapy
Yonsei University
Yonsei University
National Institutes of Health Clinical Center (CC)
Brigham and Women's Hospital
University of Southern California
Duke University
M.D. Anderson Cancer Center
Indiana University
Ohio State University Comprehensive Cancer Center
Institut Curie
Thomas Jefferson University
Institut Curie
Institut Cancerologie de l'Ouest
European Institute of Oncology
Centre Henri Becquerel
Institut Curie
Ohio State University Comprehensive Cancer Center
University Medical Center Groningen
Yale University
UNICANCER
First Affiliated Hospital of Zhejiang University
Vastra Gotaland Region
Peking University Cancer Hospital & Institute
Scripps Health
European Institute of Oncology
Samsung Medical Center